全文获取类型
收费全文 | 1455篇 |
免费 | 125篇 |
国内免费 | 35篇 |
专业分类
耳鼻咽喉 | 40篇 |
儿科学 | 78篇 |
妇产科学 | 17篇 |
基础医学 | 154篇 |
口腔科学 | 32篇 |
临床医学 | 157篇 |
内科学 | 254篇 |
皮肤病学 | 26篇 |
神经病学 | 61篇 |
特种医学 | 202篇 |
外科学 | 95篇 |
综合类 | 42篇 |
预防医学 | 156篇 |
眼科学 | 16篇 |
药学 | 95篇 |
中国医学 | 3篇 |
肿瘤学 | 187篇 |
出版年
2023年 | 3篇 |
2022年 | 6篇 |
2021年 | 12篇 |
2020年 | 13篇 |
2019年 | 16篇 |
2018年 | 33篇 |
2017年 | 29篇 |
2016年 | 20篇 |
2015年 | 33篇 |
2014年 | 35篇 |
2013年 | 62篇 |
2012年 | 56篇 |
2011年 | 48篇 |
2010年 | 60篇 |
2009年 | 61篇 |
2008年 | 43篇 |
2007年 | 62篇 |
2006年 | 38篇 |
2005年 | 72篇 |
2004年 | 53篇 |
2003年 | 26篇 |
2002年 | 39篇 |
2001年 | 35篇 |
2000年 | 32篇 |
1999年 | 41篇 |
1998年 | 59篇 |
1997年 | 57篇 |
1996年 | 52篇 |
1995年 | 44篇 |
1994年 | 45篇 |
1993年 | 43篇 |
1992年 | 25篇 |
1991年 | 42篇 |
1990年 | 23篇 |
1989年 | 45篇 |
1988年 | 59篇 |
1987年 | 27篇 |
1986年 | 22篇 |
1985年 | 32篇 |
1984年 | 13篇 |
1983年 | 4篇 |
1982年 | 8篇 |
1981年 | 9篇 |
1980年 | 12篇 |
1979年 | 15篇 |
1978年 | 6篇 |
1977年 | 9篇 |
1976年 | 15篇 |
1975年 | 5篇 |
1973年 | 4篇 |
排序方式: 共有1615条查询结果,搜索用时 31 毫秒
41.
Julia ML Brotherton 《Journal of paediatrics and child health》2014,50(12):959-965
The development of efficacious prophylactic human papillomavirus vaccines provided an opportunity for the primary prevention of related infections and diseases. Certain oncogenic human papillomaviruses that preferentially infect the genital epithelium cause cervical cancer and a substantial proportion of anal, penile, vaginal, vulvar and oropharyngeal cancers. Following extensive clinical trials demonstrating their efficacy and safety, two vaccines have been in global use for over 6 years. This review summarises the accumulated evidence regarding their high level of efficacy, safety in population usage, reductions in genital warts, infections and cervical disease following their adoption, and facilitators and barriers to achieving high vaccination coverage. The review also discusses practical issues and frequently asked questions regarding duration of effect, vaccination of women treated for cervical disease and alternate vaccination schedules, as well as the need to review cervical screening strategies in the post‐ vaccination environment. 相似文献
42.
43.
Mortality rates are lower in SIAD,than in hypervolaemic or hypovolaemic hyponatraemia: Results of a prospective observational study
下载免费PDF全文
![点击此处可从《Clinical endocrinology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
44.
45.
46.
47.
48.
Heterogeneous phenotypes of platelet and plasma von Willebrand factor in obligatory heterozygotes for severe von Willebrand disease 总被引:5,自引:0,他引:5
Mannucci PM; Lattuada A; Castaman G; Lombardi R; Colibretti ML; Ciavarella N; Rodeghiero F 《Blood》1989,74(7):2433-2436
To characterize the heterogeneity of severe (type III) von Willebrand disease (vWD), plasma and platelet von Willebrand factor antigen (vWF:Ag) and ristocetin cofactor activity (Ricof) were measured in 28 obligatory heterozygotes (ie, parents or children of probands from 15 different kindreds with severe vWD). On the average, heterozygotes had low levels of vWF in both platelets and plasma. There was, however, considerable heterogeneity, with four distinct patterns. Eleven heterozygotes had concordant reduction of vWF:Ag and Ricof in both plasma and platelets; five had low levels of vWF:Ag and Ricof in plasma contrasting with normal levels in platelets; eight had a peculiar pattern, the reverse of the above (ie, low levels in platelets and normal levels in plasma); and in one, both vWF measurements were normal in plasma and platelets. These patterns were genetically determined: they were consistent in four couples of consanguineous heterozygotes and in two couples carrying the same gene deletion. Only the remaining three heterozygotes had no clearly identifiable pattern. Other findings of this study were that although most of the heterozygotes had normal bleeding times, the 7 of 28 who had prolonged bleeding times had concordantly low levels of vWF measurements in both plasma and platelets. In conclusion, this large series of obligatory heterozygotes provides evidence for phenotypic and genotypic heterogeneity of severe vWD. 相似文献
49.
Martha L. Slattery Daniel F. Pellatt Lila E. Mullany Roger K. Wolff Jennifer S. Herrick 《Genes, chromosomes & cancer》2015,54(9):527-541
Hundreds to thousands of genes are differentially expressed in tumors when compared to nontumor colonic tissue samples. We evaluated gene expression patterns to better understand differences in colon cancer by tumor site and tumor molecular phenotype. We analyzed RNA‐seq data from tumor/normal paired samples from 175 colon cancer patients. We implemented a cross validation strategy with nonparametric tests to identify genes which displayed varying expression characteristics related to paired tumor/nontumor tissue across proximal and distal colon sites and by tumor molecular phenotypes, that is, TP53, KRAS, CpG Island Methylator Phenotype (CIMP), and microsatellite instability (MSI). We used Ingenuity Pathway Analysis (IPA) to determine networks associated with deregulated genes in our data. Genes showed significant differences in expression characteristics at the 0.01 level in both validation groups between tumor subsite (116 genes), CIMP high versus CIMP low (79 genes), MSI versus microsatellite stable (MSS) (49 genes), TP53‐mutated versus not mutated (17genes), and KRAS‐mutated versus not mutated (1 gene). Deregulated genes for CIMP high and MSI tumors were often down‐regulated. In contrast to CIMP high and MSI tumors, genes that were deregulated in TP53 were likely to be up‐regulated. ERK1, WNT, growth factors and inflammation‐related factors were focal points of both CIMP and MSI IPA networks. The MUC family of genes was up‐regulated MSI networks. Numerous genes showed differences in expression between proximal and distal tumors, nontumor proximal and distal tissue, and tumor molecular phenotype. Deregulated mucin genes appear to play an important role in MSI tumors. © 2015 Wiley Periodixzcals, Inc. 相似文献
50.
Shuo Jiao Ulrike Peters Sonja Berndt Stphane Bzieau Hermann Brenner Peter T. Campbell Andrew T. Chan Jenny Chang‐Claude Mathieu Lemire Polly A. Newcomb John D. Potter Martha L. Slattery Michael O. Woods Li Hsu 《Genetic epidemiology》2015,39(8):609-618
Identification of gene‐environment interaction (G × E) is important in understanding the etiology of complex diseases. Based on our previously developed Set Based gene EnviRonment InterAction test (SBERIA), in this paper we propose a powerful framework for enhanced set‐based G × E testing (eSBERIA). The major challenge of signal aggregation within a set is how to tell signals from noise. eSBERIA tackles this challenge by adaptively aggregating the interaction signals within a set weighted by the strength of the marginal and correlation screening signals. eSBERIA then combines the screening‐informed aggregate test with a variance component test to account for the residual signals. Additionally, we develop a case‐only extension for eSBERIA (coSBERIA) and an existing set‐based method, which boosts the power not only by exploiting the G‐E independence assumption but also by avoiding the need to specify main effects for a large number of variants in the set. Through extensive simulation, we show that coSBERIA and eSBERIA are considerably more powerful than existing methods within the case‐only and the case‐control method categories across a wide range of scenarios. We conduct a genome‐wide G × E search by applying our methods to Illumina HumanExome Beadchip data of 10,446 colorectal cancer cases and 10,191 controls and identify two novel interactions between nonsteroidal anti‐inflammatory drugs (NSAIDs) and MINK1 and PTCHD3. 相似文献